Continental Chemicals Reports Nil Deviation in Preferential Issue Utilization
Continental Chemicals Ltd · Others (Uncategorized) · 05 Nov 2026, 9:51 pm
Continental Chemicals Reports Nil Deviation in Preferential Issue Utilization Continental Chemicals Limited submitted its statement under Regulation 32 of SEBI (LODR) Regulations, 2015, confirming nil deviation or variation in fund utilization for the quarter ended 30th Sep'26. The company had raised ₹1,62,50,000 via a preferential issue on 14th Oct'19 to meet working capital requirements. The audit committee reviewed and approved the report, noting that the entire raised capital had been fully utilized by the quarter ended 31st Dec'23.
Original exchange filing (PDF)
More announcements from Continental Chemicals Ltd
- AS PER THE ATTACHED FILE · 05 Nov 2026
- AS PER THE ATTACHED FILE · 05 Nov 2026
- AS PER THE ATTACHED FILE · 05 Nov 2026
- Continental Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve AS PER THE ATTACHED FILE · 05 Nov 2026
- AS PER THE FILE ATTACHED · 21 Sept 2026
- As per the file attached · 18 Sept 2026
- AS PER THE FILE ATTACHED · 24 Aug 2026
- AS PER THE FILE ATTACAHED · 24 Aug 2026
